Contract Details
- Awarding Entity: United Nations International Children's Emergency Fund (UNICEF)
- Product: bivalent Oral Polio Vaccine (bOPV) in 10 and 20 dose presentations
- Contract Value: US$8.205 million (approximately ₹78.24 Crore)
- Execution Period: Calendar Year 2028
- Award Date: Received on August 4, 2026
Contract Context
This award is in continuation of the company's earlier disclosure dated October 3, 2025, regarding a Long-Term Agreement with UNICEF for supply of bOPV from April 1, 2026 to March 31, 2030. The previous award covered supply for Q2 CY2026 and CY2027.
Financial Impact
The contract represents a confirmed order worth approximately ₹78.24 Crore to be executed during Calendar Year 2028.